Miist Therapeutics
Phase 3Miist Therapeutics is setting a new standard in acute care with inhaled therapies that work in seconds, not hours.
Founded
2021
Focus
Drug Delivery
About
Miist Therapeutics is setting a new standard in acute care with inhaled therapies that work in seconds, not hours.
Company Info
TypePrivate
Founded2021
LocationCambridge, United States
StagePhase 3
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile